Aelis Farma Reports Its 2025 Annual Financial Results and Confirms Its 2026 Outlook
Aelis Farma announced its financial results for 2025, highlighting progress in cannabis use disorder treatment development. The 2026 outlook confirms continued clinical trial advancements. This report focuses on Aelis Farma financial results 2025 and…
Governor Signs Bill to Launch Ibogaine Clinical Trials – Magnolia Tribune
Ibogaine clinical trials legislation marks a significant step in addiction treatment research. This bill enables formal studies to evaluate ibogaine's efficacy and safety. It opens regulatory pathways for controlled psychedelic clinical trials.
Relationally anchored motivation in alcohol and cannabis use disorder: a clinical case analysis
This case analysis highlights relational motivation substance use recovery in patients with co-occurring alcohol and cannabis use disorders. Interpersonal relationships serve as key motivational anchors supporting recovery efforts. Understanding these…
Exploring GLP-1 Receptor Agonists for Addiction Treatment
GLP-1 receptor agonists addiction benefits are emerging as a promising area in addiction medicine. These medications may reduce cravings and addictive behaviors by modulating brain reward pathways. Research continues to explore their potential beyond…
Stellate Ganglion Block for Cannabis Use Disorder: Case Series Insights
This case series explores stellate ganglion block cannabis use disorder as a novel procedural intervention. It highlights the potential of sympathetic nervous system modulation in managing cannabis dependence. The findings represent early-stage research…
Evaluating Cannabis Substitution for Alcohol in a Canadian MAP
Cannabis substitution alcohol harm reduction is being evaluated within Canadian managed alcohol programs. This approach offers a potential lower-risk alternative for individuals with severe alcohol use disorder. The study provides early evidence…
Ibogaine Research Pilot Program One Step Closer to Reality After Committee Vote – Denver7
The ibogaine research pilot program in Colorado marks a significant step toward clinical investigation of this psychedelic. This program focuses on addiction treatment research while addressing cardiac safety concerns. The pilot aims to establish…
Evidence-Based Consensus on Pharmacological Management of Cannabis Dependence
The British Association for Psychopharmacology provides cannabis dependence pharmacological management guidelines based on current evidence. These guidelines highlight the limited pharmacological options and emphasize behavioral interventions. Clinicians…
Effectiveness and Clinical Predictors of Virtual Group Therapy for Cannabis Use Disorder
Virtual group therapy cannabis use disorder treatment shows promise in reducing cannabis use and cravings. This combined CBT and motivational enhancement therapy improves clinical outcomes. The study highlights key clinical predictors for treatment…
Attitudes to Drug Policy in Australia, 2001-2022/23: What Does This Mean for Drug Policy Reform in Australia?
The Australian National Drug Strategy Household Survey reveals strong public support for harm reduction services. This data highlights attitudes toward drug policy reform in Australia. Understanding these trends is essential for clinical advocacy and…